Cancer Institute of New Jersey (CINJ), Hematologic Malignancies

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Hematologic Malignancies is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    Combinatorial ixazomib and belinostat therapy induces NFE2L2-dependent apoptosis in Hodgkin and T-cell lymphoma

    Passero, F. C., Ravi, D., McDonald, J. T., Beheshti, A., David, K. A. & Evens, A. M., Jan 1 2020, In : British Journal of Haematology. 188, 2, p. 295-308 14 p.

    Research output: Contribution to journalArticle

  • Management of older Hodgkin lymphoma patients

    Evens, A. M., Carter, J., Loh, K. P. & David, K. A., Dec 6 2019, In : Hematology (United States). 2019, 1, p. 233-242 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Open Access